By Sector

By Location

By Type

Skip Navigation Links Home > Portfolio > Company Info

Company info

Aesica Pharmaceuticals

Aesica Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), which are exported to major drug producers around the world.

Deal Information

LDC completed the MBO in September 2004.

Based in Cramlington in the North East Aesica Pharmaceuticals, a £35million turnover business, employs over 140 people and has a strong product portfolio including the anti-depressants Paroxetine HCl Anhydrate, Dothiepin and a non-steroidal anti-inflammatory Flurbiprofen.

The 90-acre Cramlington site was developed by Boots in the early 1980s with BASF acquiring the site in 1995 and a new technical centre opened in 2004, bringing to the site a high specification research and development facility.

The deal involved support funding for the expansion of existing manufacturing facilities in order to increase production capacities and efficiencies.

Aesica is founded on the strong foundations of over 30 years of pharmaceutical manufacturing expertise with the aim of developing a leading pharmaceutical company in the North East.

Click here to visit company website.

Recent Transactions